Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Medicure Inc

Healthcare CA MPH

1.25CAD
0.00(0%)

Last update at 2026-06-23T13:30:00Z

Day Range

1.251.25
LowHigh

52 Week Range

0.831.43
LowHigh

Fundamentals

  • Previous Close 1.25
  • Market Cap14.09M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.17400M
  • Revenue TTM26.21M
  • Revenue Per Share TTM2.51
  • Gross Profit TTM 12.77M
  • Diluted EPS TTM-0.33

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.78300M -0.89700M 1.39M -0.75900M -6.84500M
Minority interest - - - - -
Net income -1.03900M -0.92200M 1.36M -0.72700M -6.84500M
Selling general administrative 12.74M 4.13M 4.19M 2.70M 4.58M
Selling and marketing expenses - 8.31M 7.93M 10.31M 5.36M
Gross profit 13.09M 13.56M 16.07M 12.71M 5.13M
Reconciled depreciation 2.31M 2.17M 2.06M 3.15M 2.77M
Ebit - -0.85400M 1.31M -0.57400M -7.28700M
Ebitda - 1.32M 3.37M 2.57M -4.51400M
Depreciation and amortization - 2.17M 2.06M 3.15M 2.77M
Non operating income net other - - - - -
Operating income -2.73700M -0.85400M 1.31M -0.57400M -7.28700M
Other operating expenses - 22.55M 21.87M 23.84M 19.72M
Interest expense 0.01000M 0.02M 0.02M 0.04M 0.05M
Tax provision 0.26M 0.03M 0.02M -0.03200M 0.25M
Interest income 0.21M 0.07M 0.01000M 0.08M 0.04M
Net interest income 0.17M 0.07M -0.20600M -0.34700M 0.77M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.03M 0.02M -0.03200M 0.05M
Total revenue 21.91M 21.69M 23.07M 21.74M 11.61M
Total operating expenses 24.64M 14.41M 14.88M 14.80M 13.24M
Cost of revenue 8.82M 8.14M 6.99M 9.03M 6.48M
Total other income expense net 1.79M -0.04300M 0.40M 1.68M 0.49M
Discontinued operations - - - - -
Net income from continuing ops -1.03900M -0.92200M 1.36M -0.72700M -6.84500M
Net income applicable to common shares - - - -0.72700M -6.84500M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 29.68M 28.06M 29.90M 28.41M 34.05M
Intangible assets 9.35M 8.94M 10.62M 11.21M 13.60M
Earning assets - - - - -
Other current assets - 1.14M - 0.00300M 1.39M
Total liab 8.90M 8.16M 8.89M 10.00M 14.91M
Total stockholder equity 20.78M 19.90M 21.00M 18.41M 19.15M
Deferred long term liab - - - - -
Other current liab - 0.38M 0.18M 1.04M 5.00M
Common stock - 81.01M - 80.92M 80.92M
Capital stock 81.01M 81.01M 80.92M 80.92M 80.92M
Retained earnings -66.89100M -65.85200M -64.93000M -66.29500M -65.56800M
Other liab - - - 0.70M 1.52M
Good will 3.38M 3.10M 3.18M 2.97M 2.99M
Other assets - - - 0.06M 0.16M
Cash 7.19M 6.37M 4.86M 3.69M 2.72M
Cash and equivalents - - - - -
Total current liabilities 8.39M 7.93M 8.39M 8.51M 12.31M
Current deferred revenue - 0.02M - - -
Net debt - -5.82500M - - -
Short term debt - 0.32M - - -
Short long term debt - - - - -
Short long term debt total - 0.54M - - -
Other stockholder equity - 10.72M - -6.64000M -6.49700M
Property plant equipment - - - 1.61M 1.64M
Total current assets 15.90M 15.21M 14.85M 12.55M 15.68M
Long term investments - - - - -
Net tangible assets - - - 4.22M 2.56M
Short term investments - - - - -
Net receivables 5.26M 4.79M 5.53M 4.66M 5.25M
Long term debt - - - - -
Inventory 3.28M 2.90M 3.22M 3.33M 5.14M
Accounts payable 7.93M 7.22M 7.13M 6.49M 6.39M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -5.98900M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.10M 0.07M 0.06M 0.06M 0.16M
Deferred long term asset charges - - - - -
Non current assets total 13.78M 12.85M 15.05M 15.85M 18.38M
Capital lease obligations 0.87M 0.54M 0.85M 1.17M 1.45M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.73900M -0.27000M -0.31000M -2.69400M -7.24000M
Change to liabilities - - 0.57M 0.02M -3.80200M
Total cashflows from investing activities - - - -2.69400M -7.24000M
Net borrowings -0.37000M - - -0.31600M -0.24400M
Total cash from financing activities -0.37000M -0.29700M -0.35500M -0.31600M -0.76600M
Change to operating activities - - - 0.40M 0.70M
Net income -1.03900M -0.92200M 1.36M -0.72700M -6.84500M
Change in cash 0.82M 1.51M 1.16M 0.98M -10.24900M
Begin period cash flow 6.37M 4.86M 3.69M 2.72M 12.96M
End period cash flow 7.19M 6.37M 4.86M 3.69M 2.72M
Total cash from operating activities 1.38M 2.08M 1.83M 3.99M -2.24000M
Issuance of capital stock - - - - -
Depreciation 2.31M 2.17M 2.06M 3.15M 2.77M
Other cashflows from investing activities - - - -1.87600M -1.87600M
Dividends paid - - - - -
Change to inventory -0.20700M -0.03100M 0.17M 0.47M 0.72M
Change to account receivables 0.15M 0.76M -0.86400M 0.59M 5.08M
Sale purchase of stock - - 0.00200M -0.37000M -0.52200M
Other cashflows from financing activities - 0.06M -0.31000M -2.69400M -7.24000M
Change to netincome - - - 0.08M -0.87300M
Capital expenditures 0.74M 0.27M 0.31M 0.82M 0.00200M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.33200M 0.47M -0.32600M 1.49M 2.71M
Stock based compensation 0.20M 0.29M 0.05M 0.14M 0.32M
Other non cash items -0.16500M 0.05M -1.33300M -0.02000M -1.09100M
Free cash flow 0.64M 1.81M 1.52M 3.17M -2.24200M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MPH
Medicure Inc		 - -% 1.25 - 13.48 0.54 0.81 0.42 7.84
RX
Biosyent Inc.		 -0.1 0.71% 13.94 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 - -% 0.12 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 - -% 0.50 - - 108.48 4.41 140.29 -4.258
LSL
LSL Pharma Group Inc.		 0.005 1.56% 0.33 20.75 - 1.88 1.89 2.85 10.19

Reports Covered

Stock Research & News

View All

Profile

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.

Medicure Inc

2-1250 Waverley Street, Winnipeg, MB, Canada, R3T 6C6

Key Executives

Name Title Year Born
Dr. Albert David Friesen Ph.D. Founder, CEO & Chairman of the board 1947
Dr. Neil Owens Ph.D. Pres & COO NA
Mr. Haaris Uddin B.Com., CPA Chief Financial Officer NA
Dr. Reuben Saba Ph.D. VP of Scientific & Medical Affairs NA
Ms. Jamie Gowryluk VP of Commercial Operations NA
Dr. Neil Owens Ph.D. President & COO NA
Dr. Reuben Saba Ph.D. Vice President of Scientific & Medical Affairs NA
Dr. Albert David Friesen Ph.D. Founder, CEO & Chairman of the Board 1947

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions